255 results match your criteria: "From Harvard Medical School[Affiliation]"
N Engl J Med
November 2024
From Harvard Medical School (T.G.F.) and Harvard T.H. Chan School of Public Health (D.B.) - both in Boston; and the Health Foundation, London (J.D.). Dr. Ferris was formerly the National Director for Transformation at NHS England.
Am J Ophthalmol
November 2024
Center for Global Health, Perelman School of Medicine, University of Pennsylvania (K.S.M.), Philadelphia, Pennsylvania. Electronic address:
Purpose: Pleiotropic cardiovascular benefits of sodium-glucose cotransporter 2 inhibitors (SGLT2i) due to vascular remodeling effects have been demonstrated in patients with type 2 diabetes mellitus. It is unclear whether a similar benefit may be seen for glaucoma. The purpose of this study was to assess the effect of SGLT2i on the risk of glaucoma in patients with type 2 diabetes.
View Article and Find Full Text PDFHarv Rev Psychiatry
November 2024
From Harvard Medical School (Drs. Lee, Biswas, Gutheil, Peteet, and Shah); Brigham and Women's Hospital (Drs. Lee, Biswas, Peteet, and Shah); Beth Israel Deaconess Medical Center (Dr. Gutheil); Dana-Farber Cancer Institute (Dr. Peteet), Boston, MA; Brigham and Women's Faulkner Hospital (Dr. Lee), Jamaica Plain, MA.
N Engl J Med
October 2024
From Harvard Medical School (R.F., D.B.) and the Department of Obstetrics and Gynecology, Brigham and Women's Hospital (D.B.) - both in Boston.
N Engl J Med
September 2024
From Harvard Medical School (N.D.A., L.I.I.) and the Health Policy Research Center at the Mongan Institute, Massachusetts General Hospital (L.I.I.) - both in Boston.
Harv Rev Psychiatry
September 2024
From Harvard Medical School (Drs. Pudukodu, Goldschen, Bhattacharyya, Valle, Arabelovic, Shah, Retzel, Feldman, and Amonoo); Department of Psychiatry, Brigham and Women's Hospital (Drs. Pudukodu, Goldschen, and Amonoo); Department of Neurology, Brigham and Women's Hospital (Dr. Bhattacharyya); Division of Rheumatology, Inflammation and Immunity, Brigham and Women's Hospital (Drs. Valle, Arabelovic, Shah, Retzel, and Feldman); Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute (Dr. Amonoo), Boston, MA.
N Engl J Med
September 2024
From Harvard Medical School (R.B., E.R., D.N.L., S.H.P.), Massachusetts General Hospital (E.R., D.N.L., S.H.P.), and Brigham and Women's Hospital (D.N.L.) - all in Boston.
Harv Rev Psychiatry
September 2024
From Harvard Medical School (Drs. Wozniak and Huang); Cambridge Health Alliance, Department of Psychiatry, Cambridge, MA (Drs. Wozniak and Huang).
Learning Objectives: After participating in this CME activity, the psychiatrist should be better able to:• Describe how to identify and address emotional eating in the primary care setting.
Abstract: Emotional eating (i.e.
Harv Rev Psychiatry
July 2024
From Harvard Medical School, Department of Psychiatry, Brigham and Women's Hospital, Boston, MA (Drs. Schildkrout and Raj); Department of Psychiatry, University of Toronto, University Health Network, Toronto, ON, Canada (Dr. MacGillivray); Sheppard Pratt and University of Maryland School of Medicine, Baltimore, MD (Dr. Lauterbach).
Learning Objectives After Participating In This Cme Activity, Readers Should Be Better Able To: • Describe how the symptoms of dysphoric milk ejection reflex (D-MER) affect nursing patients.• Discuss how physicians, psychologists, and clinicians can support their patients experiencing D-MER.
Abstract: Dysphoric milk ejection reflex (D-MER) is characterized by a sudden onset of profoundly negative emotions that are temporally linked to milk letdown when breastfeeding or pumping breast milk.
N Engl J Med
June 2024
From Harvard Medical School (M.L., S.S.), the Department of Medicine, Massachusetts General Hospital (D.G.M.), and Boston Health Care for the Homeless Program (D.G.M.) - all in Boston; and the Department of Family Medicine and USC Street Medicine, Keck School of Medicine, University of Southern California, Los Angeles (B.J.F.).
N Engl J Med
May 2024
From Harvard Medical School, Boston (S.S.), and the Center for Health Law and Policy Innovation, Harvard Law School, Cambridge (R.L.) - both in Massachusetts; the Kaiser Foundation Health Plan, Oakland (M.C.K.), and the Social Interventions Research and Evaluation Network, University of California, San Francisco (L.M.G.) - both in California.
Harv Rev Psychiatry
May 2024
From Harvard Medical School (Ms. Mosier-Mills and Drs. Kim and Keuroghlian), Massachusetts General Hospital, Boston, MA (Drs. Kim and Keuroghlian), The Fenway Institute, Boston, MA (Dr. Keuroghlian).
Adolescents seeking gender-affirming medical care (GAMC) face numerous barriers that may delay or inhibit their access to these services. Such obstacles include mental health professional (MHP) assessment requirements prior to initiating GAMC. MHP letters ultimately carry little benefit for patients.
View Article and Find Full Text PDFHarv Rev Psychiatry
May 2024
From Harvard Medical School, Division of Neurotherapeutics, Department of Psychiatry, Massachusetts General Hospital, Charlestown, MA.
Learning Objectives: After participating in this CME activity, the psychiatrist should be better able to:• Compare and contrast therapies used in combination with transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS) for treating MDD.
Background: Noninvasive neuromodulation, such as transcranial magnetic stimulation (TMS) and transcranial direct current stimulation (tDCS), has emerged as a major area for treating major depressive disorder (MDD). This review has two primary aims: (1) to review the current literature on combining TMS and tDCS with other therapies, such as psychotherapy and psychopharmacological interventions, and (2) to discuss the efficacy, feasibility, limitations, and future directions of these combined treatments for MDD.
Cutis
February 2024
Maciej Gracz and Dr. Lee are from Albany Medical College, New York. Dr. Jin Chung is from Harvard Medical School, Boston, Massachusetts.
Cutis
January 2024
Shivali Devjani, Ogechi Ezemma, Kristen J. Kelley, and Dr. Senna are from the Department of Dermatology, Lahey Hospital and Medical Center, Burlington, Massachusetts. Dr. Senna also is from and Dr. Jothishankar is from Harvard Medical School, Boston, Massachusetts.
Harv Rev Psychiatry
March 2024
From Harvard Medical School (Drs. Hartstein, Peck, and Torous); Department of Psychiatry and Behavioral Sciences, University of California, Davis (Dr. Yellowlees).
Harv Rev Psychiatry
March 2024
From Harvard Medical School (Ms. Beazer, Mr. Breiger, and Dr. Keuroghlian), Department of Psychiatry, Massachusetts General Hospital, Boston, MA (Dr. Keuroghlian), The Fenway Institute, Boston, MA (Dr. Keuroghlian).
Since the inclusion of gender identity disorder in the third edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-III), psychiatry and the broader medical field have made substantial alterations in their recognition of and respect for transgender and gender diverse (TGD) identities. As this recognition continues to expand, psychiatrists should be aware of both historical harm and current best care practices, especially in light of psychiatric morbidity in TGD populations relative to the general population. This article contextualizes the history of psychiatry's engagement with TGD patients and presents the gender minority stress and resilience model to frame the mental health disparities experienced by TGD people.
View Article and Find Full Text PDFHarv Rev Psychiatry
March 2024
From Harvard Medical School, Boston, MA (Mr. Petriceks, Drs. Vyas, Paudel, Donovan, Van Alphen, and Stern); Department of Psychiatry, Massachusetts General Hospital, Boston, MA (Drs. Vyas, Paudel, Donovan, Van Alphen, and Stern); Atrius Health, Boston, MA (Dr. Van Alphen).
Learning Objectives: After participating in this CME activity, the psychiatrist should be better able to:• Categorize and describe different types of abnormal involuntary movements (AIMs).• Identify assessment tools and treatment options for AIMs.
Abstract: Abnormal involuntary movements (AIMs) comprise a diverse group of movement disorders characterized by uncontrolled and unintended movements (e.
N Engl J Med
December 2023
From Harvard Medical School (D.H., R.J.Y., M.P.S.), the Department of Anesthesia, Critical Care, and Pain Medicine, Massachusetts General Hospital (D.H.), the Department of Anesthesiology, Perioperative, and Pain Medicine, Brigham and Women's Hospital (R.J.Y.), and the Anesthesiology, Critical Care, and Pain Medicine Service, VA Boston Healthcare System (M.P.S.), Boston, and the VA Bedford Healthcare System, Bedford (M.P.S.) - all in Massachusetts; and the Departments of Anesthesiology and Critical Care Medicine, Neurology, Physical Medicine and Rehabilitation, and Psychiatry and Behavioral Sciences, Johns Hopkins Medical Institutions, Baltimore, and the Departments of Physical Medicine and Rehabilitation and Anesthesiology, Walter Reed National Military Medical Center, Bethesda - both in Maryland (S.P.C.).
N Engl J Med
November 2023
From Harvard Medical School (K.T.K., D.B.K., R.W.Y.) and the Richard A. and Susan F. Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center (D.B.K., R.W.Y.) - both in Boston.
Harv Rev Psychiatry
November 2023
From Harvard Medical School (Drs. Yusufov, Pirl, Braun, Sannes, and McHugh); Dana-Farber Cancer Institute, Department of Psychosocial Oncology and Palliative Care, Boston, MA (Drs. Yusufov, Pirl, Braun, and Sauns); McLean Hospital, Belmont, MA (Dr. McHugh).
Learning Objectives After Participating In This Cme Activity, The Psychiatrist Should Be Better Able To: • Outline the risk factors involved with opioid accessibility in patients receiving treatment for cancer.• Identify factors to address in order to mitigate risk for opioid misuse during cancer care.
Abstract: Most patients with advanced cancer receive treatment for related pain.
Cutis
September 2023
Department of Dermatology, Boston Children's Hospital, Massachusetts, and the Department of Dermatology, Massachusetts General Hospital, Boston. Mia A. Mologousis also is from Tufts University School of Medicine, Boston. Dr. Hawryluk also is from Harvard Medical School, Boston.